Ineffective erythropoiesis and its treatment.
Cazzola M.
Blood. 2022 Apr 21;139(16):2460-2470. doi: 10.1182/blood.2021011045.
Ineffective Erythropoiesis: Anemia and Iron Overload.
Gupta R, Musallam KM, Taher AT, Rivella S.
Hematol Oncol Clin North Am. 2018 Apr;32(2):213-221. doi: 10.1016/j.hoc.2017.11.009. Epub 2017 Dec 29.
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia.
Mian SA, Philippe C, Maniati E, Protopapa P, Bergot T, Piganeau M, Nemkov T, Di Bella D, Morales V, Finch AJ, D'Alessandro A, Bianchi K, Wang J, Gallipoli P, Kordasti S, Kubasch AS, Cross M, Platzbecker U, Wiseman DH, Bonnet D, Bernard DG, Gribben JG, Rouault-Pierre K.
Sci Transl Med. 2023 Mar;15(685):eabn5135. doi: 10.1126/scitranslmed.abn5135. Epub 2023 Mar 1.
Ineffective erythropoiesis and osteoporosis in thalassemia: Mechanistic insights?
Means RT Jr.
Am J Med Sci. 2023 Aug;366(2):85-86. doi: 10.1016/j.amjms.2023.05.001. Epub 2023 May 4.
New insights into erythropoiesis: the roles of folate, vitamin B12, and iron.
Koury MJ, Ponka P.
Annu Rev Nutr. 2004;24:105-31. doi: 10.1146/annurev.nutr.24.012003.132306.
Ineffective Erythropoiesis in beta-Thalassaemia: Key Steps and Therapeutic Options by Drugs.
Longo F, Piolatto A, Ferrero GB, Piga A.
Int J Mol Sci. 2021 Jul 5;22(13):7229. doi: 10.3390/ijms22137229.
Ineffective erythropoiesis in sickle cell disease: new insights and future implications.
El Nemer W, Godard A, El Hoss S.
Curr Opin Hematol. 2021 May 1;28(3):171-176. doi: 10.1097/MOH.0000000000000642.
[Ineffective erythropoiesis in myelodysplastic syndrome].
Iwama A.
Rinsho Ketsueki. 2018;59(6):793-797. doi: 10.11406/rinketsu.59.793.
Pathogenic Mechanisms in Thalassemia I: Ineffective Erythropoiesis and Hypercoagulability.
Bou-Fakhredin R, Rivella S, Cappellini MD, Taher AT.
Hematol Oncol Clin North Am. 2023 Apr;37(2):341-351. doi: 10.1016/j.hoc.2022.12.005.
Ineffective erythropoiesis and thalassemias.
Rivella S.
Curr Opin Hematol. 2009 May;16(3):187-94. doi: 10.1097/MOH.0b013e32832990a4.
